Multiple Sclerosis Clinical Trial
NCT number | NCT02634567 |
Other study ID # | 107343 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2016 |
Est. completion date | December 2018 |
Verified date | August 2019 |
Source | London Health Sciences Centre |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patients diagnosed with any type of multiple sclerosis (MS) who show objective evidence of attention problems will be randomized to standard medical care (treatment as usual) or attention training, which will be completed at their home using a commercially available attention training task (Cogmed Working Memory Training - CWMT) for 5 weeks. Patients will undergo cognitive testing before and after intervention and at 6 months follow up.
Status | Completed |
Enrollment | 31 |
Est. completion date | December 2018 |
Est. primary completion date | November 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 64 Years |
Eligibility |
Gender Both: both female and male participants are being studied Age Limits Minimum Age: 18 years Maximum Age: 64 years Accepts Healthy Volunteers? No Eligibility Criteria Inclusion Criteria: - Males/Females, Ages 18-64, with any type of MS - Lower to moderate physical disability - Demonstrated impaired attention/working memory on 2 of 3 measures (Patients with a z-score lower than -1.5 on at least 2 of the 3 measures will be characterized as showing attention/working memory deficits) - Patients must have a Mac or personal computer (PC) computer at home with access to the internet Exclusion Criteria: - Clinical relapse/steroid treatment 1 month prior to study entry - Physical disability that prevents completion of study measures or training - History of severe mental illness or daily marijuana use - Those who do not meet the inclusion criteria. |
Country | Name | City | State |
---|---|---|---|
Canada | London Health Sciences Centre | London | Ontario |
Lead Sponsor | Collaborator |
---|---|
London Health Sciences Centre |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Paced Auditory Serial Addition Test | Cognitive test; Change pre- to post-test between groups | 7 months | |
Primary | Symbol Digit Modalities Test | Cognitive test; Change pre- to post-test between groups | 7 months | |
Primary | Stroop colour word test | Cognitive test; Change pre- to post-test between groups | 7 months | |
Secondary | Judgement of Line Orientation | Cognitive test; Change pre- to post-test between groups | 7 months | |
Secondary | Controlled Oral Word Association Test | Cognitive test; Change pre- to post-test between groups | 7 months | |
Secondary | California Verbal Learning Test | Cognitive test; Change pre- to post-test between groups | 7 months | |
Secondary | Brief Visual Memory Test | Cognitive test; Change pre- to post-test between groups | 7 months | |
Secondary | Delis-Kaplan Executive Function System Sorting Test | Cognitive test; Change pre- to post-test between groups | 7 months | |
Secondary | Beck Depression Inventory - Fast Screen | Non-cognitive Questionnaire; Change pre- to post-test between groups | 7 months | |
Secondary | Hospital Anxiety and Depression Scale | Non-cognitive Questionnaire; Change pre- to post-test between groups | 7 months | |
Secondary | Fatigue Severity Scale | Non-cognitive Questionnaire; Change pre- to post-test between groups | 7 months | |
Secondary | Short Form Health Survey | Non-cognitive Questionnaire; Change pre- to post-test between groups | 7 months | |
Secondary | Dysexecutive Questionnaire | Non-cognitive Questionnaire; Change pre- to post-test between groups in terms of the amount of self-reported issues with executive functions. | 7 months | |
Secondary | Cognitive Failures Questionnaire | Non-cognitive Questionnaire; Change pre- to post-test between groups in terms of the amount of self-reported cognitive issues | 7 months | |
Secondary | BRIEF Cope | Non-cognitive Questionnaire; Change pre- to post-test between groups | 7 months | |
Secondary | Social Stress and Support Interview | Non-cognitive Questionnaire; Change pre- to post-test between groups | 7 months | |
Secondary | Multiple Sclerosis Neuropsychological Screening Questionnaire | Non-cognitive Questionnaire; Change pre- to post-test between groups | 7 months | |
Secondary | Perceived Deficits Questionnaire | Non-cognitive Questionnaire; Change pre- to post-test between groups | 7 months | |
Secondary | Visual Spatial Span Board Assessment | Cognitive Test; Change pre- to post-test between groups in the amount of correct sequencing of repeated taping blocks in forward or reverse order from sequence presented by the examiner. | 7 months | |
Secondary | Digit Span | Cognitive Test; Change pre- to post-test between groups in terms of digit sequence memorized and repeated. A span of 3-9 digits will be repeated forwards and backwards after presentation from the examiner. | 7 months | |
Secondary | Arithmetic | Cognitive Test; Change pre- to post-test between groups, elementary math presented and solved without a pencil and paper. | 7 months | |
Secondary | Letter-Number Sequencing | Cognitive Test; Change pre- to post-test between groups, presented with a combination of letters and numbers; must repeat numbers in ascending order and letters in alphabetical order to examiner. | 7 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |